These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10147723)

  • 1. Methods for a model blind proficiency testing system.
    Hofherr LK; Peddecord KM; Benenson AS; Garfein RS; Francis DP; Ferran KL; Taylor RN
    Clin Lab Sci; 1992; 5(3):160-4. PubMed ID: 10147723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytic results of HIV-1 testing using blind proficiency testing.
    Peddecord KM; Benenson AS; Hofherr LK; Francis DP; Garfein RS; Ferran KL; Taylor RN; Schalla WO; Ascher MS
    Clin Lab Sci; 1992; 5(3):165-71. PubMed ID: 10147724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of nonanalytic issues in HIV-1 antibody testing using blind proficiency testing.
    Peddecord KM; Benenson AS; Hofherr LK; Garfein RS; Francis DP; Hewitt DJ; Ferran KL; Schalla WO; Hearn TL
    Clin Lab Sci; 1992; 5(3):172-6. PubMed ID: 10147725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDC's Model Performance Evaluation Program: assessment of the quality of laboratory performance for HIV-1 antibody testing.
    Schalla WO; Hearn TL; Taylor RN; Eavenson E; Valdiserri RO; Essien JD
    Public Health Rep; 1990; 105(2):167-71. PubMed ID: 2157234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: serologic testing for HIV-1 antibody--United States, 1988 and 1989.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1990 Jun; 39(22):380-3. PubMed ID: 2111436
    [No Abstract]   [Full Text] [Related]  

  • 6. Centers for Disease Control perspective on quality assurance for human immunodeficiency virus type 1 antibody testing. Model Performance Evaluation Program.
    Valdiserri RO; Taylor RN; Hearn TL; Schalla WO; Muir HW
    Arch Pathol Lab Med; 1990 Mar; 114(3):263-7. PubMed ID: 2154961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-lymphocyte immunophenotyping blind proficiency testing: a model system for CD4+ T-cells.
    Francis DP; Peddecord KM; Hofherr LK; Benenson AS; Taylor RN; Schalla WO
    Clin Lab Sci; 1999; 12(5):278-89. PubMed ID: 10623327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytic sensitivity and specificity of enzyme immunoassay results in testing for human immunodeficiency virus type 1 antibody.
    Cross GD; Schalla WO; Hancock JS; Hearn TL; Blumer SO; Taylor RN; Valdiserri RO
    Arch Pathol Lab Med; 1992 May; 116(5):477-81. PubMed ID: 1580749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of laboratory performance in testing for human immunodeficiency virus type 1 antibody. Variables associated in multivariate analyses.
    Gerber AR; Valdiserri RO; Johnson CA; Schwartz RE; Hancock JS; Hearn TL
    Arch Pathol Lab Med; 1991 Nov; 115(11):1091-6. PubMed ID: 1747026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the implementation of HIV-rapid test kits at different levels of health institutions in Ethiopia.
    Tegbaru B; Wolday D; Messele T; Meless H; Kassa D; Tesema D; Tamene W; Ahmedin Z; Adane A; Tebeje M; Gezahegn N; Birhanu H; Mengistu Y; Wuhib T; Fekadu M
    Ethiop Med J; 2007 Jul; 45(3):293-9. PubMed ID: 18330330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 proficiency testing. The American Association of Blood Banks/College of American Pathologists Program.
    Polesky HF; Hanson MR
    Arch Pathol Lab Med; 1990 Mar; 114(3):268-71. PubMed ID: 2407215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The feasibility of external blind DNA proficiency testing. I. Background and findings.
    Peterson JL; Lin G; Ho M; Chen Y; Gaensslen RE
    J Forensic Sci; 2003 Jan; 48(1):21-31. PubMed ID: 12570195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of laboratory performance in testing for human immunodeficiency virus type 1 antibody. Identification of variables associated with laboratory performance.
    Hancock JS; Taylor RN; Johnson CA; Gerber AR; Schalla WO
    Arch Pathol Lab Med; 1993 Nov; 117(11):1148-55. PubMed ID: 8239938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The feasibility of external blind DNA proficiency testing. II. Experience with actual blind tests.
    Peterson JL; Lin G; Ho M; Chen Y; Gaensslen RE
    J Forensic Sci; 2003 Jan; 48(1):32-40. PubMed ID: 12570196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From the Centers for Disease Control. Update: serologic testing for HIV-1 antibody--United States, 1988 and 1989.
    JAMA; 1990 Jul; 264(2):171-3. PubMed ID: 2192095
    [No Abstract]   [Full Text] [Related]  

  • 16. Implementation of proficiency testing in conjunction with a rechecking system for external quality assurance in tuberculosis laboratories in Mexico.
    Martinez-Guarneros A; Balandrano-Campos S; Solano-Ceh MA; Gonzalez-Dominguez F; Lipman HB; Ridderhof JC; Flisser A
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):516-21. PubMed ID: 12797692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance program for pharmacokinetic assay of antiretrovirals: ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004: a requirement for therapeutic drug monitoring.
    Holland DT; DiFrancesco R; Connor JD; Morse GD
    Ther Drug Monit; 2006 Jun; 28(3):367-74. PubMed ID: 16778721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of quality control on accuracy in enzyme immunoassay testing for human immunodeficiency virus type 1 antibodies.
    Astles JR; Lipman HB; Schalla WO; Blumer SO; Fehd RJ; Smith C; Hearn TL
    Arch Pathol Lab Med; 1998 Aug; 122(8):700-7. PubMed ID: 9701331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of laboratory performance with blind and mail-distributed proficiency testing samples.
    LaMotte LC; Guerrant GO; Lewis DS; Hall CT
    Public Health Rep; 1977; 92(6):554-60. PubMed ID: 200968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.